Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Volume?

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Nov 04, 2022 12:12pm

176 Views

Post# 35073438

RE:RE:RE:Volume?

I, for one, don't think there is holding info back. However, as RDW in not CEO till mid Feb, I think TLT is definitely holding back on any aggressive publicity push. Wouldn't suprise me that they are holding back on the IND application to time it with RDW so he can use it as a publicty point.

Dr. Mandel likely doesn't have time or interest in doing the work of getting the word out when there is so much sciencing to be done. IMO

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles